Literature DB >> 21804947

Rainbow Plasmonic Nanobubbles: Synergistic Activation of Gold Nanoparticle Clusters.

Ekaterina Y Lukianova-Hleb1, Alexander O Oginsky, Derek L Shenefelt, Rebekah A Drezek, Jason H Hafner, Mary C Farach-Carson, Dmitri O Lapotko.   

Abstract

The synergistic physical and biological effects of selective targeting and activation of plasmonic nanoparticles were studied for a transient vapor nanobubble mode. Simultaneous optical activation of two plasmon resonances in multi-nanoparticle clusters significantly improved the selectivity and efficacy of the nanobubble generation through and was termed "rainbow plasmonic nanobubbles." The rainbow nanobubble mechanism has been studied in water and in living cells in vitro. This mechanism provided maximal selectivity of the nanobubble generation in both models and therefore, can the therapeutic selectivity and optical contrast of gold nanoparticles in a heterogeneous physiological microenvironment at cell level.

Entities:  

Year:  2011        PMID: 21804947      PMCID: PMC3144574          DOI: 10.4172/2157-7439.1000104

Source DB:  PubMed          Journal:  J Nanomed Nanotechnol


  53 in total

1.  Excitation of nanoscale vapor bubbles at the surface of gold nanoparticles in water.

Authors:  V Kotaidis; C Dahmen; G von Plessen; F Springer; A Plech
Journal:  J Chem Phys       Date:  2006-05-14       Impact factor: 3.488

2.  Optical excitation and detection of vapor bubbles around plasmonic nanoparticles.

Authors:  Dmitri Lapotko
Journal:  Opt Express       Date:  2009-02-16       Impact factor: 3.894

3.  Influence of transient environmental photothermal effects on optical scattering by gold nanoparticles.

Authors:  Ekaterina Y Lukianova-Hleb; Dmitri O Lapotko
Journal:  Nano Lett       Date:  2009-05       Impact factor: 11.189

4.  Quantitative evaluation of cellular uptake and trafficking of plain and polyethylene glycol-coated gold nanoparticles.

Authors:  Christina Brandenberger; Christian Mühlfeld; Zulqurnain Ali; Anke-Gabriele Lenz; Otmar Schmid; Wolfgang J Parak; Peter Gehr; Barbara Rothen-Rutishauser
Journal:  Small       Date:  2010-08-02       Impact factor: 13.281

5.  The in vivo performance of plasmonic nanobubbles as cell theranostic agents in zebrafish hosting prostate cancer xenografts.

Authors:  Daniel S Wagner; Nikki A Delk; Ekaterina Y Lukianova-Hleb; Jason H Hafner; Mary C Farach-Carson; Dmitri O Lapotko
Journal:  Biomaterials       Date:  2010-07-14       Impact factor: 12.479

Review 6.  Targeted hyperthermia using metal nanoparticles.

Authors:  Paul Cherukuri; Evan S Glazer; Steven A Curley
Journal:  Adv Drug Deliv Rev       Date:  2009-11-10       Impact factor: 15.470

Review 7.  Nanoparticles and the brain: cause for concern?.

Authors:  Günter Oberdörster; Alison Elder; Amber Rinderknecht
Journal:  J Nanosci Nanotechnol       Date:  2009-08

8.  Constitutive and antibody-induced internalization of prostate-specific membrane antigen.

Authors:  H Liu; A K Rajasekaran; P Moy; Y Xia; S Kim; V Navarro; R Rahmati; N H Bander
Journal:  Cancer Res       Date:  1998-09-15       Impact factor: 12.701

Review 9.  Gold nanorods as contrast agents for biological imaging: optical properties, surface conjugation and photothermal effects.

Authors:  Ling Tong; Qingshan Wei; Alexander Wei; Ji-Xin Cheng
Journal:  Photochem Photobiol       Date:  2009 Jan-Feb       Impact factor: 3.421

10.  Selective prostate cancer thermal ablation with laser activated gold nanoshells.

Authors:  Joshua M Stern; Jennifer Stanfield; Wareef Kabbani; Jer-Tsong Hsieh; Jeffrey A Cadeddu
Journal:  J Urol       Date:  2007-12-20       Impact factor: 7.450

View more
  2 in total

1.  Plasmonic nanobubbles as tunable cellular probes for cancer theranostics.

Authors:  Dmitri Lapotko
Journal:  Cancers (Basel)       Date:  2011-02-23       Impact factor: 6.639

2.  Improved cellular specificity of plasmonic nanobubbles versus nanoparticles in heterogeneous cell systems.

Authors:  Ekaterina Y Lukianova-Hleb; Xiaoyang Ren; Pamela E Constantinou; Brian P Danysh; Derek L Shenefelt; Daniel D Carson; Mary C Farach-Carson; Vladimir A Kulchitsky; Xiangwei Wu; Daniel S Wagner; Dmitri O Lapotko
Journal:  PLoS One       Date:  2012-04-03       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.